Company Overview

Green Thumb Industries Inc. (GTII) is a U.S.-based cannabis consumer packaged goods company and multi-state cannabis operator engaged in the cultivation, manufacturing, distribution, and retail sale of cannabis products for medical and adult-use markets. The company operates across the regulated cannabis industry through vertically integrated operations that include cultivation facilities, processing and manufacturing assets, branded consumer products, and retail dispensaries. GTII generates revenue primarily through retail cannabis sales and branded packaged products sold through both company-owned stores and third-party channels in regulated state markets.

GTII’s core business includes its retail chain RISE Dispensaries and a portfolio of cannabis brands that span flower, edibles, concentrates, vapes, and wellness products. Key brands include Dogwalkers, Dr. Solomon’s, Good Green, Incredibles, and RYTHM. The company has positioned itself as a scaled operator focused on limited-license U.S. cannabis markets, emphasizing brand development, operational efficiency, and disciplined capital allocation. Founded in 2014 and headquartered in Chicago, Illinois, GTII expanded through organic growth, state license wins, and acquisitions, becoming one of the larger publicly traded U.S. cannabis companies by revenue and retail footprint.

Business Operations

GTII operates through vertically integrated cannabis businesses across multiple U.S. states. Its operations generally include cultivation and production facilities, branded product manufacturing, wholesale distribution, and retail dispensaries under the RISE Dispensaries banner. Revenue is primarily generated from retail sales to consumers, with additional revenue from wholesale distribution of branded products to third-party dispensaries. The company has historically emphasized operations in limited-license states where regulatory frameworks restrict the number of market participants.

The company maintains cultivation and manufacturing assets that support production of branded cannabis products across several categories, including flower, pre-rolls, edibles, tinctures, concentrates, and vaporizer products. GTII also operates through subsidiaries tied to individual state licenses and regulated entities. Its operational footprint includes both medical-only and adult-use cannabis markets. The company’s business model relies heavily on compliance capabilities, retail scale, product branding, and vertically integrated supply chains within regulated jurisdictions.

Strategic Position & Investments

GTII’s strategy has focused on disciplined expansion in high-population and limited-license cannabis markets while maintaining operational profitability and free cash flow generation relative to many industry peers. The company has invested significantly in cultivation capacity, manufacturing infrastructure, retail expansion, and branded product development. Management has consistently emphasized market selection, balance sheet discipline, and scalable consumer brands as key competitive differentiators.

The company has completed acquisitions and asset transactions to strengthen market positions in states such as Illinois, Pennsylvania, Nevada, and Massachusetts, among others. GTII continues to invest in consumer packaged goods capabilities, data-driven retail operations, and product innovation across premium and value-oriented cannabis brands. Its strategic positioning is also tied to potential long-term regulatory shifts in the U.S. cannabis industry, including expanded adult-use legalization and possible federal policy reform. Data regarding future federal regulatory outcomes remains inconclusive based on available public sources.

Geographic Footprint

GTII operates across multiple U.S. cannabis markets, with activities concentrated in states that permit medical and/or adult-use cannabis sales. The company’s headquarters are located in Chicago, Illinois, while its cultivation, manufacturing, and retail assets are distributed across key regulated markets including Illinois, Pennsylvania, New Jersey, Nevada, Massachusetts, Maryland, Minnesota, Ohio, and other states. The company’s retail operations are primarily conducted through RISE Dispensaries.

Because cannabis remains federally illegal in the United States, GTII’s operations are domestic rather than international. However, the company has operational influence across several major regional cannabis markets in the U.S. through cultivation infrastructure, wholesale distribution networks, and branded retail operations. Its market presence spans the Midwest, Northeast, and parts of the Western United States, with exposure to both mature and emerging regulated cannabis markets.

Leadership & Governance

GTII was founded by a group of investors and operators focused on building a national cannabis consumer products company during the early expansion of state-level cannabis legalization in the United States. The company’s leadership has consistently emphasized regulatory compliance, operational execution, consumer branding, and long-term market positioning within the evolving cannabis industry.

Key executives include:

• Ben Kovler – Chairman and Chief Executive Officer
• Anthony Georgiadis – Independent Director and former executive leadership participant in company development
• Cassandra Farrington – Independent Director
• David Dore – President
• Mattan Ertel – National General Counsel
• Debra Troiano – Chief Operating Officer
• Jennifer Fiderer – Chief Financial Officer

Management has publicly articulated a strategy centered on disciplined growth, profitability, strong cash flow generation, and expansion in limited-license cannabis markets. Governance practices are influenced by public company reporting obligations in both Canadian and U.S. capital markets, including disclosures contained in SEC filings and Canadian securities filings.